Publications by authors named "N Obaldia"

Article Synopsis
  • The human malaria-monkey model has been a key tool in malaria research since 1966, helping to test the effectiveness and absorption of various antimalarial drugs.
  • Over the years, researchers have used this model to study both drug-resistant and drug-susceptible strains, mimicking human malaria infections closely.
  • The model has facilitated the development of key antimalarial treatments, including artemisinin-based combination therapies and the progression of tafenoquine to clinical trials, while also aiding in the understanding of malaria’s biology and drug resistance.
View Article and Find Full Text PDF

The malaria parasite remains a major global public health challenge, and no vaccine is approved for use in humans. Here, we assessed whether strain-transcendent immunity can be achieved by repeated infection in monkeys. Sterile immunity was achieved after two homologous infections, whereas subsequent heterologous challenge provided only partial protection.

View Article and Find Full Text PDF

Background: As the elimination of malaria in Mesoamerica progresses, detection of Plasmodium vivax using light microscopy (LM) becomes more difficult. Highly sensitive molecular tools have been developed to help determine the hidden reservoir of malaria transmission in low transmission settings. In this study we compare the performance of PvLAP5 and Pvs25 qRT-PCR assays to LM for the detection of Plasmodium vivax gametocytes in field samples preserved at ambient temperature from malaria endemic regions of Panama.

View Article and Find Full Text PDF

Background: Filtration of leukocytes (WBCs) is a standard practice of malaria ex vivo cultures. To date, few studies have considered the effect of filtration or the lack thereof on the survival of Plasmodium vivax ex vivo cultures through one cycle of maturation. This study investigates the effect of WBC filtration and culture media supplementation on the survival of 48-72 h ex vivo cultures.

View Article and Find Full Text PDF

Nonimmune monkeys infected with and were cured of their infections when treated with a single oral dose of 5 mg/kg and 10 mg/kg of the 2-aminomethylphenol, JPC-3210, respectively. Corresponding mean blood elimination half-lives of JPC-3210 were lengthy at 19.1 days and 20.

View Article and Find Full Text PDF